D
Regeneron Pharmaceuticals, Inc. REGN
$744.83 $37.325.28%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 12.04% 11.85% 11.45% -0.59% -1.97%
Total Other Revenue -15.58% -17.43% 50.79% 0.78% 66.41%
Total Revenue 10.33% 10.65% 12.32% -0.54% 0.58%
Cost of Revenue 16.72% 16.60% 17.24% 7.92% 6.98%
Gross Profit 4.11% 5.79% 11.36% -8.77% -4.95%
SG&A Expenses 7.39% 11.54% 16.38% 14.62% 11.69%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- 2,533.33% 3,160.00% 92.42%
Total Operating Expenses 13.91% 15.12% 14.57% 10.52% 8.66%
Operating Income 1.66% 2.70% 7.58% -24.36% -14.78%
Income Before Tax -16.51% 34.41% 50.35% -18.33% -13.37%
Income Tax Expenses 436.67% 47.96% 71.00% -152.99% -109.40%
Earnings from Continuing Operations -20.86% 33.02% 47.90% -11.71% -3.13%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -20.86% 33.02% 47.90% -11.71% -3.13%
EBIT 1.66% 2.70% 7.58% -24.36% -14.78%
EBITDA 2.69% 3.72% 8.45% -20.84% -12.61%
EPS Basic -21.60% 30.81% 46.40% -12.29% -2.77%
Normalized Basic EPS 6.24% 4.40% 11.93% -15.34% -11.79%
EPS Diluted -20.81% 29.81% 46.00% -12.55% -2.87%
Normalized Diluted EPS 7.24% 3.61% 11.61% -15.60% -11.97%
Average Basic Shares Outstanding 0.94% 1.69% 1.03% 0.65% -0.37%
Average Diluted Shares Outstanding 0.00% 2.47% 1.32% 0.96% -0.18%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings